Aethlon Medical Inc: what the price is pricing in

There is no current book value reading for Aethlon Medical Inc: its latest is from December 31, 2023. Switch lens below to see the other readings and how trading the gap would have done.

No published rating for Aethlon Medical Inc: data-quality checks not passed. The readings below run our models backwards for research and show how trading the gap would have done; they are not a valuation or a rating. The valuation page shows the models and their status.

What return on equity is the price paying for?

No current reading. The latest is from December 31, 2023: the figures this lens needs have not been filed recently enough (or no longer apply), so there is no position this quarter.

Quarters with a position110 long, 11 short, since June 30, 2021

Beat the S&P 50010 of 1190.9% of quarters held

Strategy against the index+861.6%cumulative; worst fall -28.3%

$10,000 became$117,047S&P 500 bought and held: $12,732

Over time

The return on equity that justifies the price-to-book ratio, (P/B)(r − g) + g with an 8.5% required return and 2.5% long-run growth, against the return the company delivered last year.

Return on equity delivered Return on equity the price implies Long quarter Short quarter. Lower panel: the share price at each quarter end, adjusted for later share splits and spin-offs (the table below gives the price as traded).

$10,000 trading the gap vs the S&P 500

StrategyS&P 500, buy and hold Hypothetical, before costs. The strategy holds the S&P 500 and only changes on a signal: it switches into AEMD in long quarters and adds a short of AEMD in short quarters. The gap between the lines is what the signal added or lost.

Skill or luck?

In plain English: Across 11 quarters with a position, this lens beat the S&P 500 in 10, by +25.5% a quarter on average. That stands out clearly from chance. One company is a small sample: the results across all companies are the better guide.

Positions	Quarters	Beat the S&P 500	Average vs S&P 500, a quarter	Typical (median), a quarter	A year	Confidence (t)	Evidence
Longs	0	—	—	—	—	—	—
Shorts	11	90.9%	+25.5%	+22.1%	+127.7%	3.31	Strong evidence
All positions	11	90.9%	+25.5%	+22.1%	+127.7%	3.31	Strong evidence

Each position is measured against the S&P 500 over the same quarter: a long earns the stock's return minus the index's, a short the index's minus the stock's. "A year" compounds the per-quarter results. Evidence: strong at a t-statistic of 2 or more, some from 1.5; "worse" when the result is that far below zero; one company's history is a small sample, so read these alongside the results across all companies.

Every quarter (11)

From	Price paid	Return on equity the price implies	Return on equity delivered	Position	AEMD	S&P 500
December 31, 2023	$2.19	2.5%	-75.1%	Short	−23.3%	+10.4%
September 30, 2023	$0.23	2.5%	-75.1%	Short	−4.8%	+11.6%
June 30, 2023	$0.36	2.5%	-75.1%	Short	−36.1%	−3.2%
March 31, 2023	$0.38	2.5%	-70.3%	Short	−5.3%	+8.7%
December 31, 2022	$0.28	2.5%	-60.7%	Short	+35.7%	+7.5%
September 30, 2022	$0.58	2.5%	-56.4%	Short	−51.7%	+7.6%
June 30, 2022	$1.12	2.6%	-78.8%	Short	−48.2%	−4.9%
March 31, 2022	$1.46	2.6%	-55.1%	Short	−23.3%	−16.1%
December 31, 2021	$1.86	2.6%	-48.0%	Short	−21.5%	−4.6%
September 30, 2021	$3.86	2.6%	-42.6%	Short	−51.8%	+11.1%
June 30, 2021	$4.92	3.0%	-83.7%	Short	−21.5%	+0.6%

Price paid: the closing price that day as traded, before any later share split.

How the test works

At each quarter end since March 2010 we rebuild the models from Aethlon Medical Inc's quarters ending at least 90 days earlier (and no more than 200 days before that), using the figures as later filed, including any restatement, and value them at that day's close, adjusted for later share splits and spin-offs so that price and share count are on the same basis. A wide enough gap is a long or a short for one quarter (growth 10 points; margin and return on equity 5 points; a PEG under 0.75 or over 3), measured on total return against the S&P 500. The rules were set before the test. No trading or borrowing costs; today's list of companies. Not investment advice. All companies and the results across them.

Compare with peers

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Aethlon Medical Inc's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aethlon Medical Inc.